T1	Disorder 20 73;82 90	Drug Reaction with Eosinophilia and Systemic Symptoms syndrome
N1 	Reference T1 UMLS:C3541994	Drug Reaction with Eosinophilia and Systemic Symptoms syndrome
T3	Pharmacological_substance 186 205	antiretroviral drug
N1000 	Reference T3 MeSH:D044966	antiretroviral drug
T4	Pharmacological_substance 327 340	triamcinolone
N1001 	Reference T4 MeSH:D014221	triamcinolone
T5	Disorder 355 359	pain
N2 	Reference T5 UMLS:C0030193	pain
T6	Disorder 370 392	postherpetic neuralgia
N3 	Reference T6 UMLS:C0032768	postherpetic neuralgia
T7	Disorder 448 466	Cushing's syndrome
N4 	Reference T7 UMLS:C0010481	Cushing's syndrome
T8	Pharmacological_substance 508 521	triamcinolone
N1002 	Reference T8 MeSH:D014221	triamcinolone
T9	Pharmacological_substance 538 556	protease inhibitor
N1003 	Reference T9 MeSH:D011480	protease inhibitor
T10	Pharmacological_substance 580 594	antiretroviral
T11	Pharmacological_substance 635 653	protease inhibitor
N1004 	Reference T11 MeSH:D011480	protease inhibitor
T14	Disorder 762 783	adverse drug reaction
N5 	Reference T14 UMLS:C0041755	adverse drug reaction
T15	Disorder 799 812;823 862;871 879	Drug Reaction with Eosinophilia and Systemic Symptoms syndrome
N6 	Reference T15 UMLS:C3541994	Drug Reaction with Eosinophilia and Systemic Symptoms syndrome
T17	Disorder 864 869;871 879	DRESS syndrome
N7 	Reference T17 UMLS:C3541994	DRESS syndrome
T18	Disorder 911 936	hypersensitivity syndrome
T19	Disorder 983 988	fever
N8 	Reference T19 UMLS:C0015967	fever
T20	Disorder 990 994	rash
N9 	Reference T20 UMLS:C0015230	rash
T21	Disorder 996 1011	lymphadenopathy
N10 	Reference T21 UMLS:C0497156	lymphadenopathy
T22	Disorder 1055 1067	eosinophilia
N11 	Reference T22 UMLS:C1636667	eosinophilia
N12 	Reference T22 UMLS:C0014457	eosinophilia
T23	Disorder 1119 1133	DRESS syndrome
N13 	Reference T23 UMLS:C3541994	DRESS syndrome
T12	Pharmacological_substance 1099 1110	raltegravir
N1005 	Reference T12 MeSH:D000068898	raltegravir
T24	Pharmacological_substance 683 694	raltegravir
N1006 	Reference T24 MeSH:D000068898	raltegravir
T25	Pharmacological_substance 0 11	Raltegravir
N1007 	Reference T25 MeSH:D000068898	Raltegravir
T27	Subject 259 299	A 55-year-old HIV-positive African woman
T2	Disorder 75 80;82 90	DRESS syndrome
N14 	Reference T2 UMLS:C3541994	DRESS syndrome
N15 	Reference T2 UMLS:C3541994	DRESS syndrome
T28	Subject 245 257	same patient
T34	Disorder 206 223	adverse reactions
N16 	Reference T34 UMLS:C0559546	adverse reactions
T36	Coreferring_mention 416 419	she
T37	Disorder 958 971	skin reaction
N17 	Reference T37 UMLS:C0178298	skin reaction
N18 	Reference T37 UMLS:C0496955	skin reaction
T38	Disorder 1016 1042	internal organ involvement
T39	Pharmacological_substance 1193 1211	protease inhibitor
N1008 	Reference T39 MeSH:D011480	protease inhibitor
T41	Speculation_cue 1149 1158	potential
T42	Speculation_cue 1080 1086	should
T45	Pharmacological_substance 663 682	integrase inhibitor
N1009 	Reference T45 MeSH:D019429	integrase inhibitor
T44	Coreferring_mention 566 577	The patient
T46	Coreferring_mention 721 729	the drug
T47	Coreferring_mention 731 742	the patient
